Table of Content

1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Introduction and Overview
1.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Type
3 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2019-2024)
4 Global Market Growth Trends Analysis
4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2019-2024)
4.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends Analysis by Regions
4.2.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Revenue Market Size by Regions (2019-2024)
4.2.3 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2019-2024)
4.2.4 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2019-2024)
4.2.5 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2019-2024)
4.2.6 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2019-2024)
4.2.7 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2019-2024)
5 North America
5.1 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries
5.1.1 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2019-2024)
5.2 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Types
5.3 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries
6.1.1 Asia Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2019-2024)
6.2 Asia Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Types
6.3 Asia Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries
7.1.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2019-2024)
7.2 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Types
7.3 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries
8.1.1 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2019-2024)
8.2 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Types
8.3 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries
9.1.1 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2019-2024)
9.2 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Types
9.3 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Competition, by Players
10.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players Market Share in 2023
10.2.2 Top 6 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players Head Office, Business Provided
10.4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Mergers & Acquisitions
10.5 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) New Entrants and Expansion Plans
11 Players Profiles11.1 Sanofi S.A.
11.1.1 Sanofi S.A. Company Profile
11.1.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
11.1.3 Sanofi S.A. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
11.1.4 Sanofi S.A. Business Overview
11.1.5 Recent Developments and Plans
11.2 Reckitt Benckiser Group PLC
11.2.1 Reckitt Benckiser Group PLC Company Profile
11.2.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
11.2.3 Reckitt Benckiser Group PLC Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
11.2.4 Reckitt Benckiser Group PLC Business Overview
11.2.5 Recent Developments and Plans
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Company Profile
11.3.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
11.3.3 Pfizer Inc. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
11.3.4 Pfizer Inc. Business Overview
11.3.5 Recent Developments and Plans
11.4 GlaxoSmithKline Plc
11.4.1 GlaxoSmithKline Plc Company Profile
11.4.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
11.4.3 GlaxoSmithKline Plc Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
11.4.4 GlaxoSmithKline Plc Business Overview
11.4.5 Recent Developments and Plans
11.5 Sun Pharmaceutical Industries Ltd
11.5.1 Sun Pharmaceutical Industries Ltd Company Profile
11.5.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
11.5.3 Sun Pharmaceutical Industries Ltd Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
11.5.4 Sun Pharmaceutical Industries Ltd Business Overview
11.5.5 Recent Developments and Plans
11.6 Assertio Therapeutics, Inc.
11.6.1 Assertio Therapeutics, Inc. Company Profile
11.6.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
11.6.3 Assertio Therapeutics, Inc. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
11.6.4 Assertio Therapeutics, Inc. Business Overview
11.6.5 Recent Developments and Plans
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Profile
11.7.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
11.7.3 Johnson & Johnson Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
11.7.4 Johnson & Johnson Business Overview
11.7.5 Recent Developments and Plans
11.8 Bayer AG
11.8.1 Bayer AG Company Profile
11.8.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
11.8.3 Bayer AG Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
11.8.4 Bayer AG Business Overview
11.8.5 Recent Developments and Plans
11.9 Horizon Therapeutics plc
11.9.1 Horizon Therapeutics plc Company Profile
11.9.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
11.9.3 Horizon Therapeutics plc Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
11.9.4 Horizon Therapeutics plc Business Overview
11.9.5 Recent Developments and Plans
11.10 Iroko Pharmaceuticals Inc.
11.10.1 Iroko Pharmaceuticals Inc. Company Profile
11.10.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Overview
11.10.3 Iroko Pharmaceuticals Inc. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Performance (2019-2024)
11.10.4 Iroko Pharmaceuticals Inc. Business Overview
11.10.5 Recent Developments and Plans
12 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecast Market Analysis by Type
12.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast by Type (2024-2030)
13 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecast Market Analysis by Application
13.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast by Application (2024-2030)
14 Global Market Growth Forecast Analysis
14.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecast Market Size (2024-2030)
14.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends Forecast Analysis by Regions
14.2.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Forecast Market Size by Regions (2024-2030)
14.2.2 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecast Market Size (2024-2030)
14.2.3 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecast Market Size (2024-2030)
14.2.4 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecast Market Size (2024-2030)
14.2.5 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecast Market Size (2024-2030)
14.2.6 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecast Market Size (2024-2030)
15 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Dynamic Analysis
15.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends Analysis
15.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers Analysis
15.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges Analysis
15.4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints Analysis